Skip to main content
. 2022 Feb 18;13:408–424. doi: 10.18632/oncotarget.28191

Table 2. Effect of PI3K/Akt/mTOR inhibitors on GR function.

Compound Major Targets Gene activation by glucocorticoids Gene inhibition by glucocorticoids
Rapamycin mTORC1 Blunted (validated array) Exaggerated (validated array)
OSI-027 mTORC1/2 N/A N/A
Wortmannin PI3K Blunted Exaggerated
LY-294002 PI3K Blunted (validated array) Exaggerated (validated array)
NVP-BEZ235 PI3K/mTOR N/A N/A
AZD8055 PI3K/mTOR Blunted Exaggerated
MK-2206 Akt1/2/3 N/A N/A

HaCaT keratinocytes were pretreated with REDD1 inhibitors (1–10 uM) for hrs, and treated with FA (1 uM) for 6–24 hrs. The level of gene activation/repression was determined by Luciferase reporter assay. References: [137, 140]. Abbreviation: N/A: not assessed.